Exploration Capital, LLC's Form 4 filing
Fresh Tracks Therapeutics, Inc. (FRTX) · filed Mar 21, 2024
- Accession no.
- 0001213900-24-024839
- Filed
- Mar 21, 2024
- Trade date
- Mar 19-20, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $270.17. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Exploration Capital, LLCCIK 0002003514 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 | Common Stock | PPurchaseAcquired | +10 | $0.90 | +$9 | 963,852 | Direct | |
| Mar 20, 2024 | Common Stock | PPurchaseAcquired | +287 | $0.91 | +$261.17 | 964,139 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.